4.0 Article

The CMV early enhancer/chicken β actin (CAG) promoter can be used to drive transgene expression during the differentiation of murine embryonic stem cells into vascular progenitors

期刊

BMC CELL BIOLOGY
卷 9, 期 -, 页码 -

出版社

BMC
DOI: 10.1186/1471-2121-9-2

关键词

-

资金

  1. Wellcome Trust [069369, 065940] Funding Source: Medline

向作者/读者索取更多资源

Background: Mouse embryonic stem cells cultured in vitro have the ability to differentiate into cells of the three germ layers as well as germ cells. The differentiation mimics early developmental events, including vasculogenesis and early angiogenesis and several differentiation systems are being used to identify factors that are important during the formation of the vascular system. Embryonic stem cells are difficult to transfect, while downregulation of promoter activity upon selection of stable transfectants has been reported, rendering the study of proteins by overexpression difficult. Results: CCE mouse embryonic stem cells were differentiated on collagen type IV for 4-5 days, Flk1(+) mesodermal cells were sorted and replated either on collagen type IV in the presence of VEGFA to give rise to endothelial cells and smooth muscle cells or in collagen type I gels for the formation of vascular tubes. The activity of the CMV and beta-actin promoters was downregulated during selection of stable transfectants and during differentiation to the Flk1 stage, while the CMV immediate enhancer/beta-actin promoter in the pCAGIPuro-GFP vector led to 100% of stably transfected undifferentiated and differentiated cells expressing GFP. To further test this system we expressed syndecan-2 and -4 in these cells and demonstrated high levels of transgene expression in both undifferentiated cells and cells differentiated to the Flk1 stage. Conclusion: Vectors containing the CAG promoter offer a valuable tool for the long term expression of transgenes during stem cell differentiation towards mesoderm, while the CMV and beta-actin promoters lead to very poor transgene expression during this process.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.0
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Hematology

ICAM-1-expressing neutrophils exhibit enhanced effector functions in murine models of endotoxemia

Abigail Woodfin, Martina Beyrau, Mathieu-Benoit Voisin, Bin Ma, James R. Whiteford, Peter L. Hordijk, Nancy Hogg, Sussan Nourshargh

Article Biochemistry & Molecular Biology

Aspirin inhibits the production of proangiogenic 15(S)-HETE by platelet cyclooxygenase-1

Francesca Rauzi, Nicholas S. Kirkby, Matthew L. Edin, James Whiteford, Darryl C. Zeldin, Jane A. Mitchell, Timothy D. Warner

FASEB JOURNAL (2016)

Article Oncology

Underlying chronic inflammation alters the profile and mechanisms of acute neutrophil recruitment

Bin Ma, James R. Whiteford, Sussan Nourshargh, Abigail Woodfin

JOURNAL OF PATHOLOGY (2016)

Article Cell Biology

NRF2 Orchestrates the Metabolic Shift during Induced Pluripotent Stem Cell Reprogramming

Kate E. Hawkins, Shona Joy, Juliette M. K. M. Delhove, Vassilios N. Kotiadis, Emilio Fernandez, Lorna M. Fitzpatrick, James R. Whiteford, Peter J. King, Juan P. Bolanos, Michael R. Duchen, Simon N. Waddington, Tristan R. McKay

CELL REPORTS (2016)

Editorial Material Pharmacology & Pharmacy

Translating the matrix

James R. Whiteford, Samantha Arokiasamy, Giulia De Rossi

BRITISH JOURNAL OF PHARMACOLOGY (2019)

Article Rheumatology

Antibody-mediated inhibition of syndecan-4 dimerisation reduces interleukin (IL)-1 receptor trafficking and signalling

Lars Godmann, Miriam Bollmann, Adelheid Korb-Pap, Ulrich Koenig, Joanna Sherwood, Denise Beckmann, Katja Muehlenberg, Frank Echtermeyer, James Whiteford, Giulia De Rossi, Thomas Pap, Jessica Bertrand

ANNALS OF THE RHEUMATIC DISEASES (2020)

Review Immunology

Syndecan-3 in Inflammation and Angiogenesis

Samantha Arokiasamy, Michaela J. M. Balderstone, Giulia De Rossi, James R. Whiteford

FRONTIERS IN IMMUNOLOGY (2020)

Article Cell Biology

Agrin induces long-term osteochondral regeneration by supporting repair morphogenesis

Suzanne E. Eldridge, Aida Barawi, Hui Wang, Anke J. Roelofs, Magdalena Kaneva, Zeyu Guan, Helen Lydon, Bethan L. Thomas, Anne-Sophie Thorup, Beatriz F. Fernandez, Sara Caxaria, Danielle Strachan, Ahmed Ali, Kanatheepan Shanmuganathan, Costantino Pitzalis, James R. Whiteford, Frances Henson, Andrew W. McCaskie, Cosimo De Bari, Francesco Dell'Accio

SCIENCE TRANSLATIONAL MEDICINE (2020)

Article Cell Biology

ROR2 blockade as a therapy for osteoarthritis

Anne-Sophie Thorup, Danielle Strachan, Sara Caxaria, Blandine Poulet, Bethan L. Thomas, Suzanne E. Eldridge, Giovanna Nalesso, James R. Whiteford, Costantino Pitzalis, Thomas Aigner, Roger Corder, Jessica Bertrand, Francesco Dell'Accio

SCIENCE TRANSLATIONAL MEDICINE (2020)

Article Cell Biology

Mesoglycan exerts its fibrinolytic effect through the activation of annexin A2

Raffaella Belvedere, Elva Morretta, Emanuela Pessolano, Nunzia Novizio, Alessandra Tosco, Amalia Porta, James Whiteford, Mauro Perretti, Amelia Filippelli, Maria Chiara Monti, Antonello Petrella

Summary: Mesoglycan induces the release of plasmin in endothelial cells by triggering a series of events starting from SDC4 activation, followed by src complex and PKC alpha activation, ultimately leading to the phosphorylation of ANXA2 and its translocation to the plasma membrane. This cascade mechanism connects mesoglycan with SDC4-(PKC alpha-src) and ANXA2, ultimately facilitating the release of plasmin and degradation of fibrin sleeves.

JOURNAL OF CELLULAR PHYSIOLOGY (2021)

Article Hematology

Pathological Angiogenesis Requires Syndecan-4 for Efficient VEGFA-Induced VE-Cadherin Internalization

Giulia De Rossi, Maria Vahatupa, Enrico Cristante, Samantha Arokiasamy, Sidath E. Liyanage, Ulrike May, Laura Pellinen, Hannele Uusitalo-Jarvinen, James W. Bainbridge, Tero A. H. Jarvinen, James R. Whiteford

Summary: This study establishes the crucial role of SDC4 in pathological angiogenesis, particularly in eye diseases and tumor development. SDC4 is identified as a downstream mediator of VEGFA-induced vascular endothelial cadherin internalization, representing a potential target for antiangiogenic therapies.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2021)

Article Critical Care Medicine

CD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary Fibrosis

Konstantin Tsoyi, Xiaoliang Liang, Giulia De Rossi, Stefan W. Ryter, Kevin Xiong, Sarah G. Chu, Xiaoli Liu, Bonna Ith, Lindsay J. Celada, Freddy Romero, Matthew J. Robertson, Anthony J. Esposito, Sergio Poli, Souheil El-Chemaly, Mark A. Perrella, YuanYuan Shi, James Whiteford, Ivan O. Rosas

Summary: CD148 phosphatase is downregulated in lung fibroblasts of patients with idiopathic pulmonary fibrosis (IPF), and its overexpression can reverse the profibrotic phenotype. Lack of CD148 leads to exacerbated fibrosis, while activation of CD148 reduces p62 accumulation and inhibits NF-kappa B-mediated profibrotic gene expression, exerting anti-fibrotic effects. Targeting the CD148 phosphatase with activating ligands like SDC2-pep may represent a potential therapeutic strategy for IPF.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)

Article Biochemistry & Molecular Biology

Mesoglycan connects Syndecan-4 and VEGFR2 through Annexin A1 and formyl peptide receptors to promote angiogenesis in vitro

Emanuela Pessolano, Raffaella Belvedere, Nunzia Novizio, Amelia Filippelli, Mauro Perretti, James Whiteford, Antonello Petrella

Summary: This study demonstrated that Mesoglycan promotes cell motility and angiogenesis by acting on the key receptor Syndecan-4. The research revealed that Mesoglycan exerts its pro-angiogenic effects by activating three interconnected molecular axes.

FEBS JOURNAL (2021)

Article Biochemistry & Molecular Biology

Roles of Syndecan-4 in cardiac injury and repair

Faheem Shaik, Michaela, J. M. Balderstone, Samantha Arokiasamy, James R. Whiteford

Summary: The purpose of this review is to explore the biological insights into the role of Syndecan-4 in both the injured heart and later during cardiac repair and remodeling.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2022)

Article Multidisciplinary Sciences

Neutrophil breaching of the blood vessel pericyte layer during diapedesis requires mast cell-derived IL-17A

Regis Joulia, Idaira Maria Guerrero-Fonseca, Tamara Girbl, Jonathon A. Coates, Monja Stein, Laura Vazquez-Martinez, Eleanor Lynam, James Whiteford, Michael Schnoor, David Voehringer, Axel Roers, Sussan Nourshargh, Mathieu-Benoit Voisin

Summary: This study reveals that perivascular mast cells regulate the final steps of neutrophil diapedesis through the outer pericyte layer via IL-17A production, potentially providing insights for inflammatory disorders driven by increased neutrophil diapedesis.

NATURE COMMUNICATIONS (2022)

暂无数据